Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Cleveland BioLabsBioanalytical SystemsBIOQUALAIkido PharmaHedgePath Pharmaceuticals
Price Information
Current Price$2.24$5.24$66.70$0.82$0.07
52 Week RangeN/AN/AN/AN/AN/A
Beat the Market™ Rank
Overall Score0.
Analysis Score0.
Community Score3.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$25.54 million$56.93 million$59.66 million$28.48 million$18.52 million
Average Volume3,520,68617,5831465,091,0952,232
Sales & Book Value
Annual Revenue$1.11 million$43.62 million$39.48 million$10,000.00N/A
Price / Sales23.011.301.502,847.73N/A
CashflowN/A$0.21 per share$4.14 per shareN/AN/A
Price / CashN/A24.9616.11N/AN/A
Book Value$0.09 per share$1.02 per share$27.46 per share$2.18 per share($0.01) per share
Price / Book24.895.142.430.37N/A
Net Income$-2,650,000.00$-790,000.00$2.83 million$-4,180,000.00$-4,550,000.00
Trailing P/E Ratio0.00N/A14.530.000.00
Forward P/E Ratio
Net Margins-220.62%-3.94%9.23%N/AN/A
Return on Equity (ROE)-169.32%-12.39%16.16%-88.61%N/A
Return on Assets (ROA)-102.29%-2.51%10.77%-83.62%-246.03%
Annual PayoutN/AN/A$0.70N/AN/A
Dividend YieldN/AN/A1.05%N/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity RatioN/A1.89%N/AN/AN/A
Current Ratio1.69%0.53%3.39%26.92%6.76%
Quick Ratio1.69%0.49%3.39%26.92%6.76%
Ownership Information
Institutional Ownership Percentage3.58%11.16%N/A0.93%N/A
Insider Ownership Percentage1.88%11.46%39.24%4.22%4.80%
Shares Outstanding11.40 million10.86 million890,00034.92 million370.45 million
Next Earnings Date8/12/2020 (Estimated)8/12/2020 (Estimated)9/11/2020 (Estimated)8/12/2020 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.